THERATECHNOLOGIES INC (THTX)

CA88338H7040 - Common Stock

1.3  0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
69.823M
5.71%		80.057M
14.66%		81.764M
2.13%		90.864M
11.13%
EBITDA
YoY % growth
-16.488M
-59.30%		-27.437M
-66.41%		-7.312M
73.35%		14.511M
298.45%
EBIT
YoY % growth
-25.236M
-33.74%		-39.908M
-58.14%		-10.627M
73.37%		8.043M
175.68%
Operating Margin
-36.14%-49.85%-13.00%8.85%
EPS
YoY % growth
-0.34
-17.24%		-2.00
-488.24%		-0.95
52.50%		-0.38
59.67%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.03
92.28%
Revenue
Q2Q % growth		21.991M
25.31%
EBITDA
Q2Q % growth		2.036MN/AN/AN/A
EBIT
Q2Q % growth		1.803M
122.70%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 -0.10
77.27%		-0.130.0320.74%
Q4 2023
Q2Q % growth		 -0.08
77.78%		-0.250.1768.30%
Q3 2023
Q2Q % growth		 -0.03
90.63%		-0.300.2789.87%
Q2 2023
Q2Q % growth		 -0.40
58.33%		-0.26-0.14-55.34%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 16.247M
-18.39%		20.705M-4.458M-21.53%
Q4 2023
Q2Q % growth		 23.452M
9.48%		24.064M-612K-2.54%
Q3 2023
Q2Q % growth		 20.855M
0.21%		21.683M-828K-3.82%
Q2 2023
Q2Q % growth		 17.549M
-8.92%		22.66M-5.111M-22.56%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS73.91% -12.49% 4% -5.08%
Revenue-1.17% -7.76% 0% -4.27%